Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anders Borde"'
Autor:
Rydvikha Govender, Susanna Abrahmsén-Alami, Anette Larsson, Anders Borde, Alexander Liljeblad, Staffan Folestad
Publikováno v:
Pharmaceutics, Vol 12, Iss 8, p 771 (2020)
Independent individualization of multiple product attributes, such as dose and drug release, is a crucial overarching requirement of pharmaceutical products for individualized therapy as is the unified integration of individualized product design wit
Externí odkaz:
https://doaj.org/article/895a797c16b74de7bc97beebfc433dd8
Autor:
Alexander Liljeblad, Staffan Folestad, Anette Larsson, Anders Borde, Rydvikha Govender, Susanna Abrahmsén-Alami
Publikováno v:
Pharmaceutics
Volume 12
Issue 8
Pharmaceutics, Vol 12, Iss 771, p 771 (2020)
Volume 12
Issue 8
Pharmaceutics, Vol 12, Iss 771, p 771 (2020)
Independent individualization of multiple product attributes, such as dose and drug release, is a crucial overarching requirement of pharmaceutical products for individualized therapy as is the unified integration of individualized product design wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc74dc91c9d39e03727d941ed41b2f01
Publikováno v:
Journal of Pharmaceutical Sciences. 103:3171-3175
Azo-bonded prodrugs of 5-aminosalicylic acid (mesalazine)-sulfasalazine, balsalazide, and olsalazine, which are used in the treatment of ulcerative colitis, rely on colonic bacteria to cleave the azo bond and liberate the active drug in the large int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d5f956bc671b83d5846b747cf694f2
https://doi.org/10.1002/jps.24103
https://doi.org/10.1002/jps.24103
Autor:
Karl J. Box, Sara B. E. Andersson, Søren Astrup Jørgensen, Uwe Muenster, Per Artursson, Kung I. Feng, Jennifer B. Dressman, Anette Müllertz, Mark McAllister, Christel A. S. Bergström, Edmund Kostewicz, René Holm, Stefania Beato, Anders Borde, Robert Taylor, Julian Thinnes, Marcus E. Brewster, Gavin Halbert
Publikováno v:
European Journal of Pharmaceutical Sciences. 57:173-199
Preformulation measurements are used to estimate the fraction absorbed in vivo for orally administered compounds and thereby allow an early evaluation of the need for enabling formulations. As part of the Oral Biopharmaceutical Tools (OrBiTo) project
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1c9405ec6971dc559058a4bfb6739d
https://doi.org/10.1016/j.ejps.2013.10.015
https://doi.org/10.1016/j.ejps.2013.10.015
Publikováno v:
European Journal of Pharmaceutical Sciences. 57:200-206
The objective of this study was to develop and evaluate an in vitro method to investigate bacterial-mediated luminal degradation of drugs in colon in humans. This would be a valuable tool for the assessment of drug candidates during early drug develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc9cb70e1d31faf15abae9b32f528b9
https://doi.org/10.1016/j.ejps.2013.10.001
https://doi.org/10.1016/j.ejps.2013.10.001
Autor:
Anna-Lena Ungell, Christer Tannergren, Mareike Lutz, Anders Borde, Caroline Wingolf, Åsa Sjöberg
Publikováno v:
European Journal of Pharmaceutical Sciences. 48:166-180
The purpose of this study was to evaluate the use of human intestinal tissue in Ussing chamber to predict oral and colonic drug absorption and intestinal metabolism. Data on viability, correlation between apparent permeability coefficients (P(app)) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::472d48ecbfb7ee697dad00fb13b4c682
https://doi.org/10.1016/j.ejps.2012.10.007
https://doi.org/10.1016/j.ejps.2012.10.007